Kane Biotech Stock Today
| KNBIF Stock | USD 0.09 0.02 18.36% |
Performance12 of 100
| Odds Of DistressLess than 28
|
Kane Biotech is trading at 0.0898 as of the 20th of April 2024. This is a -18.36 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0898. Kane Biotech has about a 28 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. Equity ratings for Kane Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of March 2024 and ending today, the 20th of April 2024. Click here to learn more.
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. The company has 124.83 M outstanding shares. More on Kane Biotech
Moving against Kane OTC Stock
| 0.75 | ZTLLF | Zonetail | PairCorr |
| 0.73 | WXIBF | WuXi Biologics | PairCorr |
| 0.7 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.57 | CSLLY | CSL | PairCorr |
| 0.57 | CMXHF | CSL Limited | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Kane OTC Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Kane Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Kane Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | Mark AhrensTownsend |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Kane Biotech [KNBIF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kane Biotech's market, we take the total number of its shares issued and multiply it by Kane Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kane Biotech classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 124.83 M outstanding shares.
Kane Biotech has accumulated about 2.53 M in cash with (2.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Kane Biotech Probability Of Bankruptcy
Ownership AllocationKane Biotech maintains a total of 124.83 Million outstanding shares. Kane Biotech holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kane Ownership Details
Kane Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Kane Biotech jumping above the current price in 90 days from now is about 15.7%. The Kane Biotech probability density function shows the probability of Kane Biotech otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Kane Biotech has a beta of 0.9236. This indicates Kane Biotech market returns are reactive to returns on the market. As the market goes up or down, Kane Biotech is expected to follow. Additionally, kane Biotech has an alpha of 0.8754, implying that it can generate a 0.88 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Kane Biotech to move above the current price in 90 days from now is about 15.7 (This Kane Biotech probability density function shows the probability of Kane OTC Stock to fall within a particular range of prices over 90 days) .
Kane Biotech Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Kane Biotech market risk premium is the additional return an investor will receive from holding Kane Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Kane Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Kane Biotech's alpha and beta are two of the key measurements used to evaluate Kane Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.01 | |||
| Standard Deviation | 5.97 | |||
| Variance | 35.6 | |||
| Risk Adjusted Performance | 0.1069 |
Kane Stock Against Markets
Picking the right benchmark for Kane Biotech otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Kane Biotech otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Kane Biotech is critical whether you are bullish or bearish towards Kane Biotech at a given time. Please also check how Kane Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kane Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Kane Biotech Corporate Directors
Kane Biotech corporate directors refer to members of a Kane Biotech board of directors. The board of directors generally takes responsibility for the Kane Biotech's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Kane Biotech's board members must vote for the resolution. The Kane Biotech board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Mark Nawacki | Director | Profile | |
| Sarah Prichard | Director | Profile | |
| Rashieda Gluck | Director | Profile | |
| Arvind Joshi | Director | Profile |
How to buy Kane OTC Stock?
Before investing in Kane Biotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Kane Biotech. To buy Kane Biotech stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Kane Biotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Kane Biotech stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Kane Biotech stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Kane Biotech stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Kane Biotech, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Kane Biotech?
The danger of trading Kane Biotech is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Kane Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Kane Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Kane Biotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kane Biotech. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Kane OTC Stock analysis
When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |